Русский
The impact of the COVID-19 infection epidemic on the provision of health care for people living with HIV
DOI: https://dx.doi.org/10.18565/epidem.2021.11.3.19-27
Ladnaia N.N., Kozyrina N.V., Babikhina K.A., Mikhailov A.V., Egorova N.V., Godlevskaya M.V., Semenchenko M.V., Zograbyan L.S., Pokrovsky V.V.
1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) Treatment Preparedness Coalition, Saint Petersburg, Russia; 3) «E.B.A.» Association, Saint Petersburg, Russia; 4) UNAIDS Regional Office for Eastern Europe and Central Asia, Moscow, Russia
Materials and methods. The investigation was conducted using an anonymous survey on the Internet from July 08 to 31, 2020. The responses of 590 HIV-positive respondents and 262 HIV-negative ones were an investigation object.
Results. The COVID-19 pandemic demonstrated a negative impact on the provision of health care for HIV infection in the Russian Federation; however, the size of this problem was not as large as expected. Among PLHIV on antiretroviral therapy (ART), 70.5% reported that they had no problems in receiving antiretroviral drugs (ARVDs). 4.1% missed ARVDs due to the inability to get them at the AIDS center. Symptoms characteristic of COVID-19 were present in the majority of PLHIV (55.3%); while 52.7% of the HIV-negative respondents were examined for COVID-19, as were only 28.1% among PLHIV. Among PLHIV, 23.5% were found to have markers for COVID-19 (95% CI, 17.5–30.7). Among the HIV-negative respondents, 6.5% were positive for COVID-19 (95% CI, 2.9–10.9). 41.4% of PLHIV reported COVID-19 to the AIDS center. The majority of PLHIV respondents who had experienced coronavirus infection were men (51.3%), those who were aged 35-44 years (71.8%), and had a long life experience with HIV. The respondents predominantly reported that their condition was moderate during COVID-19.
Conclusion. The investigation showed the negative impact of the COVID-19 pandemic on the provision of health care for HIV infection in the Russian Federation, but the majority of respondents who identified themselves as PLHIV reported that they had no problems in receiving ARVDs. Among the study participants, those who identified themselves as HIV-infected were probably more susceptible to COVID-19 than respondents who identified themselves as HIV-negative. In the presence of symptoms characteristic of COVID-19, PLHIV were 2 times less likely than HIV-negative respondents to be examined for coronavirus infection and less likely to seek medical advice.
Literature
1. Coronavirus disease ( COVID-19) Situation Report – 163. Data as received by WHO from national authorities by 10:00 CEST, 1 July 2020. WHO, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200701- COVID-19-sitrep-163.pdf?sfvrsn=c202f05b_2 2. COVID-19 Weekly Epidemiological Update. Edition 46, published 29 June 2021. WHO, 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-29-june-2021 3. Информационный бюллетень 2021 г. Предварительные эпидемиологические оценочные данные. ЮНЭЙДС, 2021. https://www. unaids.org/ru/resources/fact-sheet [Global HIV & AIDS statistics. Fact sheet, 2021. HIV ESTIMATES]. UNAIDS, 2021. https://www.unaids.org/ru/resources/fact-sheet 4. Blanco J.L., Ambrosioni J., Garcia F., Martínez E., Soriano A., Mallolas J. et al. COVID-19 in HIV Investigators. COVID-19 in patients with HIV: clinical case series. Lancet HIV 2020; Apr 15. pii: S2352-3018(20)30111-9 5. Härter G., Spinner C.D., Roider J., Bickel M., Krznaric I., Grunwald S. et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020, May 11. doi: 10.1007/s15010-020-01438-z 6. Gervasoni C., Meraviglia P., Riva A., Giacomelli A., Oreni L., Minisci D. et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin. Infect. Dis. 2020, May 14. pii: ciaa579. doi: 10.1093/cid/ciaa579 7. Guo W., Ming F., Dong Y. et al. A Survey for COVID-19 among HIV/AIDS Patients in Two Districts of Wuhan, China. Preprint research paper, The Lancet, 2020. 8. Wu Q., Chen T., Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J. Med. Virol. 2020, May 13. doi: 10.1002/jmv.26006 9. Karmen-Tuohy S., Carlucci P.M., Zacharioudakis I.M., Zervou F.N., Rebick G. et al. Outcomes among HIV-positive patients hospitalized with COVID-19. medRxiv. https://www.medrxiv.org/content/10.1101/2020.05.07.20094797v1 10. Docherty A.B., Harrison E.M., Green C.A. et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterization protocol. medRxiv preprint. DOI: https://doi.org/10.1101/2020. 04.23.20076042 11. Inciartea A., Gonzalez-Cordona A., Rojasa J. et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS 2020; 34(12): 1775–1780. DOI: 10.1097/QAD. 0000000000002643. 12. Gao Z., Xu Y., Sun C., Wang X., Guo Y., Qiu S. et al. A systematic review of asymptomatic infections with COVID-19. J. Microbiol. Immunol. Infect. 202010.1016/j.jmii.2020.05.001. doi:10.1016/j.jmii.2020.05.001 13. Wang Q.Q., Kaelber D.C. Xu, R. et al. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol. Psychiatry (2020). https://doi.org/10.1038/s41380-020-00880-7. 14. Ssentongo P., Heilbrunn E.S., Ssentongo A.E. et al. Prevalence of HIV in patients hospitalized for COVID-19 and associated mortality outcomes: a systematic review and meta-analysis. Presented at: IDWeek 2020; October 21–25, 2020. Poster 393. https://www.infectiousdiseaseadvisor.com/home/meetings/idweek-2020-hiv-in-depth/people-with-hiv-higher-susceptibility-and-mortality-to-coronavirus-in-us/ 15. Дробышевская Е.В., Жукова Е.В., Ватулян А.К. Клинико-эпидемиологическая характеристика пациентов с сочетанной патологией ВИЧ + COVID-19 в Московской области. Сборник тезисов VIII Конгресса с международным участием «Контроль и профилактика инфекций, связанных с оказанием медицинской помощи (ИСМП-2020)». М.: ЦНИИ эпидемиологии Роспотребнадзора, 2020. Drobyshevskaya E., Zhukova Е., Vatulian А. [Clinical and epidemiological profile of patients with HIV + COVID-19 co-infections in the Moscow Region. Collection of abstracts of VIII Congress with international participation «Control and prevention of health care-associated infections (HCAI-2020)»]. Moscow: Central Research Institute of Epidemiology, 2020. 16. Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19. N. Engl. J. Med. 2020. doi: 10.1056/NEJMoa2001282 17. Q&A: HIV, antiretrovirals and COVID-19? WHO, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-on-COVID-19-hiv-and-antiretrovirals
About the Autors
Natalia N. Ladnaia, Cand. Biol. Sci., Senior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being; nladnaia@hotmail.com; 0000-0003-2994-151X; Scopus Author ID: 6603455486
Nadezhda V. Kozyrina, Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; nad-kozyrina@yandex.ru; http://orcid.org/0000-0001 -5134-0054
Ksenia A. Babikhina, Monitoring Expert, International Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPCru); kbabikhina@itpcru.org; http://orcid.org/0000-0002-5963-7706
Alexey V. Mikhailov, Head of Monitoring Section, International Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPCru); aleksey.mikhailov@itpcru.org; http://orcid.org/0000-0003-0288-8077
Natalia V. Yegorova, Monitoring Expert, International Treatment Preparedness Coalition in Eastern Europe and Central Asia (ITPCru); natalya.egorova@itpcru.org; http://orcid.org/ 0000-0002-7694-8338
Maria V. Godlevskaya, Project Coordinator, «E.B.A.» Association; m.godlevskaya@gmail. com
Marina V. Semenchenko, Cand. Med. Sci., Regional Adviser, UNAIDS Regional Support Team for Eastern Europe and Central Asia; semenchenkom@unaids.org
Lev S. Zohrabyan, Cand. Med. Sci., Strategic Information Adviser, UNAIDS Regional Support Team for Eastern Europe and Central Asia; ZohrabyanL@unaids.org; http://orcid.org/ 0000-0003-0952-599X
Professor Vadim V. Pokrovsky, Academician of the Russian Academy of Sciences, MD, Head, HIV Department, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; pokrovsky.vad@yandex.ru; https://orcid.org/0000-0002-9514-7288; Scopus Author ID: 7202457043
Similar Articles
